Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX)

160 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q4 2020.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46,493,166 shares of 86,559,040 outstanding shares and own 54% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (3,308,000 shares), WELLINGTON MANAGEMENT GROUP LLP (2,615,443 shares), BlackRock Inc. (2,320,406 shares), BOXER CAPITAL, LLC (2,287,782 shares), CITADEL ADVISORS LLC (2,111,518 shares), EVENTIDE ASSET MANAGEMENT, LLC (1,946,000 shares), VANGUARD GROUP INC (1,851,833 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,830,439 shares), Nantahala Capital Management, LLC (1,798,453 shares), and STATE STREET CORP (1,699,720 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.